๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

โœ Scribed by Shi-Ming Lin; Ming-Lung Yu; Chuan-Mo Lee; Rong-Nan Chien; I-Shyan Sheen; Chia-Ming Chu; Yun-Fan Liaw

Book ID
116651206
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
232 KB
Volume
46
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Does interferon therapy for chronic hepa
Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?
โœ Anna S. F. Lok ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 413 KB

Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an

Varying incidence of cirrhosis and hepat
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
โœ Michiko Shindo; Arai Ken; Tadao Okuno ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa

Prevalence of hbeag and anti-hbe in chro
Prevalence of hbeag and anti-hbe in chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma in korea
โœ Chung-Yong Kim; Soon-Kee Bae; Hie-Won L. Hann; W. Thomas London; Baruch S. Blumb ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB

The prevalence of HBeAg was studied in Korean patients with chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma. There is an independent association of HBeAg prevalence with age and diagnosis. These findings are discussed in terms of a developmental model for primary hepatocellu